GL1X · GenesisL1 explorer

Ligand · AWB

AWB · [(2R,3S,6S,7R,8R)-3-[(3-formamido-2-oxidanyl-phenyl)carbonylamino]-8-hexyl-2,6-dimethyl-4,9-bis(oxidanylidene)-1,5-dioxonan-7-yl] 3-methylbutanoate

AWB, [(2R,3S,6S,7R,8R)-3-[(3-formamido-2-oxidanyl-phenyl)carbonylamino]-8-hexyl-2,6-dimethyl-4,9-bis(oxidanylidene)-1,5-dioxonan-7-yl] 3-methylbutanoate (C28 H40 N2 O9, 548.6 g/mol), in the MolNFT structures on GenesisL1: bound in 5…

Component
AWB
Formula
C28 H40 N2 O9
Class
ligand
Structures
5
PDB entries
5

Binding sites

AWB in 5 structures; the first of them:

  • 8AB7 · Complex III2 from Yarrowia lipolytica, atovaquone and antimycin A bound · AWB C507 · binds ALA13, TYR16, VAL17, GLN22, LEU26, TRP30, ASN31, GLY33 and 12 more
  • 8ABH · Complex III2 from Yarrowia lipolytica, antimycin A bound, b-position · AWB C506 · binds ALA13, TYR16, VAL17, GLN22, LEU26, TRP30, ASN31, GLY33 and 12 more
  • 8ABI · Complex III2 from Yarrowia lipolytica,antimycin A bound, int-position · AWB C506 · binds ALA13, TYR16, VAL17, GLN22, LEU26, TRP30, ASN31, GLY33 and 12 more
  • 8ABJ · Complex III2 from Yarrowia lipolytica, antimycin A bound, c-position · AWB C506 · binds ALA13, TYR16, VAL17, GLN22, LEU26, TRP30, ASN31, SER34 and 11 more
  • 8ABL · Complex III2 from Yarrowia lipolytica, with decylubiquinol and antimycin A, consensus… · AWB C507 · binds ALA13, TYR16, VAL17, GLN22, LEU26, TRP30, ASN31, GLY33 and 12 more

Residues it binds most

ALA 10, LEU 10, SER 10, TYR 10, ASN 10, ASP 10, GLN 10, LYS 10, MET 10, TRP 10 (residue and the binding sites it lines).

Found with

  • CDL · Cardiolipin
  • HEC · Heme C
  • HEM · Protoporphyrin IX containing Fe
  • PC1 · 1,2-diacyl-sn-glycero-3-phosphocholine
  • PTY · Phosphatidylethanolamine
  • XP4 · 1,2-dimyristoyl-sn-glycero-3-phosphate
  • LMT · Dodecyl-beta-D-maltoside
  • FES · Fe2/s2 (inorganic) cluster
  • AOQ · 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.